Jonathan McGuire - RA Medical CEO Director
| RMEDDelisted Stock | USD 0.68 0.02 2.86% |
Insider
Jonathan McGuire is CEO Director of RA Medical Systems
| Age | 60 |
| Phone | 760 804 1648 |
| Web | https://www.ramed.com |
Jonathan McGuire Latest Insider Activity
Tracking and analyzing the buying and selling activities of Jonathan McGuire against RA Medical stock is an integral part of due diligence when investing in RA Medical. Jonathan McGuire insider activity provides valuable insight into whether RA Medical is net buyers or sellers over its current business cycle. Note, RA Medical insiders must abide by specific rules, including filing SEC forms every time they buy or sell RA Medical'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Jonathan McGuire over a year ago Payment of tradable shares by Jonathan McGuire of RA Medical subject to Rule 16b-3 |
RA Medical Management Efficiency
The company has return on total asset (ROA) of (0.4789) % which means that it has lost $0.4789 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (3.2525) %, meaning that it created substantial loss on money invested by shareholders. RA Medical's management efficiency ratios could be used to measure how well RA Medical manages its routine affairs as well as how well it operates its assets and liabilities.RA Medical Systems currently holds 124.17 K in liabilities with Debt to Equity (D/E) ratio of 0.16, which may suggest the company is not taking enough advantage from borrowing. RA Medical Systems has a current ratio of 4.73, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about RA Medical's use of debt, we should always consider it together with its cash and equity.
Similar Executives
| Showing other executives | INSIDER Age | ||
| Jason Cook | Bluejay Diagnostics | 43 | |
| DVM DVM | ReShape Lifesciences | N/A | |
| Fuad Ahmad | IRIDEX | 55 | |
| JD MBA | SINTX Technologies | 60 | |
| Mark Feinberg | Bluejay Diagnostics | N/A | |
| Blake Gurfein | Tivic Health Systems | 41 | |
| Ryan Sabia | Tivic Health Systems | 37 | |
| M Harrison | NanoVibronix | N/A | |
| Sanjay Ahuja | Tivic Health Systems | N/A | |
| Danielle Watson | Heart Test Laboratories | 43 | |
| Laurent Duhoux | Nuwellis | N/A | |
| Patrick Mercer | IRIDEX | 53 | |
| Rob Scott | Nuwellis | N/A | |
| Veronica Cai | Tivic Health Systems | 48 | |
| Sandra Eayrs | Nuwellis | N/A | |
| Jennifer Ernst | Tivic Health Systems | 57 | |
| Harold MD | NanoVibronix | 71 | |
| BS MS | SINTX Technologies | N/A | |
| William MD | Nuwellis | N/A | |
| Kenneth CPA | Bluejay Diagnostics | 44 | |
| Jody Dahlman | ReShape Lifesciences | N/A | |
Management Performance
| Return On Equity | -3.25 | |||
| Return On Asset | -0.48 |
RA Medical Systems Leadership Team
Elected by the shareholders, the RA Medical's board of directors comprises two types of representatives: RA Medical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of RMED. The board's role is to monitor RA Medical's management team and ensure that shareholders' interests are well served. RA Medical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, RA Medical's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Tiah Reppas, Chief VP | ||
| Jonathan McGuire, CEO Director | ||
| Maria Villanueva, VP Officer | ||
| Al MBA, Quality Clinical | ||
| Brian Conn, Principal CFO |
RMED Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is RA Medical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -3.25 | |||
| Return On Asset | -0.48 | |||
| Operating Margin | (307.60) % | |||
| Current Valuation | (8.89 M) | |||
| Shares Outstanding | 6.46 M | |||
| Shares Owned By Insiders | 36.84 % | |||
| Shares Owned By Institutions | 11.00 % | |||
| Number Of Shares Shorted | 81.45 K | |||
| Price To Book | 0.86 X | |||
| Price To Sales | 604.06 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| BTC | Bitcoin | |
| TRX | TRON | |
| BNB | Binance Coin |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Other Consideration for investing in RMED Stock
If you are still planning to invest in RA Medical Systems check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the RA Medical's history and understand the potential risks before investing.
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |